Your browser does not support JavaScript!

Santé humaine biotechnologies domaine d'application

505 entreprises et organismes intervenants dans le domaine 'Santé humaine', classés par activité.

Rejoignez la communauté
Trouvez du matériel
PFIZER
est cité dans une actualité de Labiotech.eu
Le 26/09/2024
How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market
Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the '90s. The post How Pfizer’s decision in the ’90s cost them a...
www.labiotech.eu
PFIZER
est cité dans une actualité de Labiotech.eu
Le 22/12/2023
The big pharma race against deadly RSV steps up in 2023 
GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition. The post The big pharma race against deadly RSV steps up in 2023 ...
www.labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 27/11/2023
Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA 
Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter...
www.labiotech.eu
Une question a été posée - Le 08/11/2023
1 entreprise(s)
Image Système de purification d'eau Milli-Q® IQ 7000
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Le 03/11/2023
How French pharma giant Sanofi is betting big on AI
The benefits of artificial intelligence (AI) in shaping clinical research and trials have given rise to many new AI-driven biotech startups. According to a recent report, the number of AI companies...
www.labiotech.eu
LILLY FRANCE
est cité dans une actualité de Labiotech.eu
Le 18/07/2023
Hope for Alzheimer’s patients after Lilly drug results
Eli Lilly and Company has presented full results from its phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic...
www.labiotech.eu
PFIZER
est cité dans une actualité de Labiotech.eu
Le 13/07/2023
Pfizer kicks $25M into CellCentric 
U.K.-based biotechnology company CellCentric has received a strategic investment from Pfizer including $25m to help finance further development of inobrodib, its first-in-class p300/CBP inhibitor to...
www.labiotech.eu
Nouvelle réponse - Le 06/07/2023

Quel est l'état de différenciation des macrophages de la lignée? (plûtot monocytes/M0 ou déjà différencié en M1/M2)

InvivoGen sas
a répondu :

Bonjour,

L'état de différentiation des monocytes est M0.

N'hésitez pas à me contacter si vous avez d'autres questions.

Cordialement,

Une question a été posée - Le 05/07/2023
Logo InvivoGen sas
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Le 02/06/2023
Sanofi drug reduces disease activity in relapsing MS
New data, being presented in a late-breaking session at the 2023 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, demonstrate that frexalimab, Sanofi’s novel second-generation...
www.labiotech.eu
Charger plus d'actualités